Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2
CA 2358873 A1 · Owner: Lofton-Day, Catherine E. · Inventors: Lofton-Day, Catherine E.; Gilbert, Teresa; Holloway, James L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Epidermal growth factor-like domains appear in a large number of proteins that perform critical biological functions, such as the regulation of cellular differentiation. Zntr2 is a new member of this group of proteins.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 20, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 20, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 20, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.